Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options Executive summary* of the report from the 3rd AFNET/EHRA consensus conference

Paulus Kirchhof*, Gregory Y. H. Lip, Isabelle C. Van Gelder, Jeroen Bax, Elaine Hylek, Stefan Kaeaeb, Ulrich Schotten, Karl Wegscheider, Giuseppe Boriani, Michael D. Ezekowitz, Hans-Christoph Diener, Hein Heidbuchel, Deirdre A. Lane, Luis Mont, Stephan Willems, Paul Dorian, Panos Vardas, Guenter Breithardt, A. John Camm

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

65 Citations (Web of Science)


There are exciting new developments in several areas of atrial fibrillation (AF) management that carry the hope of improving outcomes in AF patients. This paper is an executive summary that summarises the proceedings from the 3rd AFNET/EHRA consensus conference on atrial fibrillation, held in Sophia Antipolis from November 7th to 9th 2010, shortly after the release of the new ESC guidelines on AF. The conference was jointly organised by the German Atrial Fibrillation competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). This executive summary report covers four sections: 1. Risk factors and risk markers for AF, 2. Pathophysiological classification of AF, 3. Relevance of monitored AF duration for AF-related outcomes, and 4. Perspectives and needs for implementing better antithrombotic therapy.
Original languageEnglish
Pages (from-to)1012-1019
JournalThrombosis and Haemostasis
Issue number6
Publication statusPublished - Dec 2011


  • Acquired coagulation disorders
  • vitamin K-dependent factors
  • stroke / prevention
  • thrombin
  • atrial fibrillation

Cite this